News and Trends 14 Jul 2016
French Biotech that makes Drugs faster and cheaper IPO’s for €31M
Pharnext has successfully completed its IPO on the Euronext Paris exchange, allowing it to move forward with Phase II and III trials for Neurological diseases that include Alzheimer's. Based in…